Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$11.67 - $33.01 $394,889 - $1.12 Million
-33,838 Reduced 19.76%
137,389 $4.32 Million
Q3 2023

Nov 13, 2023

SELL
$13.56 - $18.47 $37,357 - $50,884
-2,755 Reduced 1.58%
171,227 $2.6 Million
Q2 2023

Aug 11, 2023

BUY
$8.57 - $15.44 $1.49 Million - $2.69 Million
173,982 New
173,982 $2.69 Million

Others Institutions Holding CVRX

About CVRx, Inc.


  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $247M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.